ℹ️
🇬🇧
Search
Search for people relevant for "externí kontrola kvality"
externí kontrola kvality
Person
Class
Person
Publication
Programmes
Export current view
prof. MUDr. Petr Zatloukal CSc.
External person at Third Faculty of Medicine
2 classes
83 publications
Classes
class
Selected Topics on Diagnostics of Lung Cancer
CCOC7837 |
Third Faculty of Medicine
class
Diagnosis and treatment of lung cancer
CCOC8879 |
Third Faculty of Medicine
Publications
publication
Interdisciplinary consensus for predictive testing of activation mutations of the epidermal growth factor receptor (EGFR) in non-small cell lung cancer
2011 |
Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Central Library of Charles University
publication
Endogenous and exogenous oestrogen exposure in Women and Lung cancer
2014 |
Third Faculty of Medicine
publication
Follow-up of expensive pneumo-oncological treatment of advanced non-small cell lung cancer in the I. line of the TULUNG register in the Czech Republic
2013 |
Faculty of Medicine in Pilsen, First Faculty of Medicine, Central Library of Charles University
publication
New options of expensive pneumo-oncological therapy for advanced non-small-cell lung carcinoma (NSCLC) in the first line based on morphological and molecular genetic diagnosis in the Czech Republic
2012 |
Faculty of Medicine in Pilsen, First Faculty of Medicine, Central Library of Charles University
publication
Clinical registry TULUNG
2012 |
Faculty of Medicine in Pilsen, Third Faculty of Medicine
publication
Monitoring of the expensive pneumooncological tratment of the advanced non-small cell lung cancer (NSCLC) in the 1st line in the TULUNG registry in the Czech Republic
2012 |
Third Faculty of Medicine, First Faculty of Medicine
publication
The effect of bexarotene on atorvastatin pharmacokinetics: results from a phase I trial of bexarotene plus chemotherapy in patients with advanced non-small cell lung cancer
2012 |
Third Faculty of Medicine
publication
A phase I pharmacokinetic study of bexarotene with vinorelbine and cisplatin in patients with advanced non-small-cell lung cancer (NSCLC)
2012 |
Third Faculty of Medicine
publication
Randomized Phase 2b Study of Pralatrexate Versus Erlotinib in Patients With Stage IIIB/IV Non-Small-Cell Lung Cancer (NSCLC) After Failure of Prior Platinum-Based Therapy
2012 |
Third Faculty of Medicine
publication
A phase III randomized study of gemcitabine and cisplatin with or without PF-3512676 (TLR9 agonist) as first-line treatment of advanced non-small-cell lung cancer
2012 |
Third Faculty of Medicine
Load more publications (73)
Loading network view...